Laboratory Other Operating Expenses from 2010 to 2025

LH Stock  USD 230.15  3.19  1.37%   
Laboratory's Other Operating Expenses is increasing with slightly volatile movements from year to year. Other Operating Expenses is estimated to finish at about 12.5 B this year. Other Operating Expenses is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. View All Fundamentals
 
Other Operating Expenses  
First Reported
1989-03-31
Previous Quarter
B
Current Value
3.1 B
Quarterly Volatility
B
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Laboratory financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory's main balance sheet or income statement drivers, such as Interest Expense of 218.7 M, Total Revenue of 13.7 B or Gross Profit of 2 B, as well as many indicators such as Price To Sales Ratio of 1.57, Dividend Yield of 0.012 or PTB Ratio of 3.26. Laboratory financial statements analysis is a perfect complement when working with Laboratory Valuation or Volatility modules.
  
Check out the analysis of Laboratory Correlation against competitors.

Latest Laboratory's Other Operating Expenses Growth Pattern

Below is the plot of the Other Operating Expenses of Laboratory of over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Laboratory. It is also known as Laboratory overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Laboratory's Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Laboratory's overall financial position and show how it may be relating to other accounts over time.
Other Operating Expenses10 Years Trend
Slightly volatile
   Other Operating Expenses   
       Timeline  

Laboratory Other Operating Expenses Regression Statistics

Arithmetic Mean8,544,253,438
Geometric Mean6,889,655,176
Coefficient Of Variation43.70
Mean Deviation3,083,909,258
Median9,959,600,000
Standard Deviation3,733,550,251
Sample Variance13939397.5T
Range12.5B
R-Value0.94
Mean Square Error1602010.9T
R-Squared0.89
Slope740,950,919
Total Sum of Squares209090962.2T

Laboratory Other Operating Expenses History

202512.5 B
202411.9 B
202311.4 B
202212.7 B
202112.8 B
202011 B
201910.2 B

About Laboratory Financial Statements

Investors use fundamental indicators, such as Laboratory's Other Operating Expenses, to determine how well the company is positioned to perform in the future. Although Laboratory's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Other Operating Expenses11.9 B12.5 B

Currently Active Assets on Macroaxis

Check out the analysis of Laboratory Correlation against competitors.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.05)
Dividend Share
2.88
Earnings Share
8.85
Revenue Per Share
155.052
Quarterly Revenue Growth
0.098
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.